Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Wojciech M Fendler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5083-9168; OpenAlex author ID A5046777203. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Co-author DOI 10.1038/s41467-024-50999-2↗
  2. Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review. Last author DOI 10.1016/j.pan.2023.01.007↗
  3. DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis. Co-author DOI 10.3390/cancers14174077↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zuzanna Nowicka · 2 shared papers, 2023–2024 · strength 0.43
  2. Dipanjan Chowdhury · 1 shared paper, 2024 · strength 0.20
  3. Alexander Spektor · 1 shared paper, 2024 · strength 0.20
  4. Yajie Sun · 1 shared paper, 2024 · strength 0.20
  5. Agnieszka Smolinska · 1 shared paper, 2022 · strength 0.15
  6. Patryk Moskwa · 1 shared paper, 2022 · strength 0.15
  7. Markus M. Lerch · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.